Medical Director, Vascular Care
Renown Institute for Heart and Vascular Health
reno, Nevada, United States
Dr. Bloch serves as Medical Director of Vascular Medicine and Anticoagulation Services at the Renown Medical Center Institute for Heart and Vascular Health. Dr. Bloch has served as a principal investigator on numerous clinical trials, most recently focused in the field of device therapy for hypertension and novel lipid lowering drugs. His academic work has been published in multiple journals and textbooks, and he is currently the co-author of the UpToDate hypertension page. He is a frequent participant in educational projects around the nation and internationally, focused on best practices in the management of hypertension, dyslipidemia, anticoagulation, vascular disease, and heart disease and stroke prevention.
Disclosure(s): Amgen Inc: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Coravie: Consulting Fees (e.g., advisory boards) (Ongoing); corcept: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); esperion: Consulting Fees (e.g., advisory boards) (Ongoing); idorsia: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); mineralyx: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); novartis: Consulting Fees (e.g., advisory boards) (Ongoing); Recor Medical, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
RENAL DENERVATION TREATMENT FOR UNCONTROLLED HYPERTENSION | INNOVATIVE TECHNOLOGY UPDATE
Sunday, March 8, 2026
8:00 AM - 9:10 AM EST
Sunday, March 8, 2026
12:52 PM - 12:59 PM EST
Reimbursement and Setting up an HTN Program
Sunday, March 8, 2026
12:59 PM - 1:05 PM EST
Sunday, March 8, 2026
1:09 PM - 1:16 PM EST
Sunday, March 8, 2026
1:22 PM - 1:30 PM EST
Monday, March 9, 2026
10:20 AM - 10:40 AM EST